GENESIS 2026 | Phillip Sanders | Team Building y Fundraising

Philipp is an Investment Analyst at IndieBio San Francisco, where he focuses on identifying and supporting the next generation of therapeutics and human health companies. With a PhD in Chemical Biology from The Scripps Research Institute and experience spanning drug discovery, engineered biology, RNA engineering and biophysics, Philipp brings a unique perspective at the intersection of cutting-edge science, biotechnology and venture investing.